- Home
- BMRN vs PAG Comparison
BMRN vs PAG Comparison
Compare BMRN & PAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- PAG
- Stock Information
- Founded
- BMRN 1996
- PAG 1990
- Country
- BMRN United States
- PAG United States
- Employees
- BMRN N/A
- PAG N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- PAG Retail-Auto Dealers and Gas Stations
- Sector
- BMRN Health Care
- PAG Consumer Discretionary
- Exchange
- BMRN Nasdaq
- PAG Nasdaq
- Market Cap
- BMRN 12.1B
- PAG 12.1B
- IPO Year
- BMRN 1999
- PAG 1996
- Fundamental
- Price
- BMRN $59.01
- PAG $175.22
- Analyst Decision
- BMRN Buy
- PAG Buy
- Analyst Count
- BMRN 23
- PAG 6
- Target Price
- BMRN $93.73
- PAG $174.17
- AVG Volume (30 Days)
- BMRN 1.8M
- PAG 221.7K
- Earning Date
- BMRN 08-04-2025
- PAG 07-30-2025
- Dividend Yield
- BMRN N/A
- PAG 2.86%
- EPS Growth
- BMRN 152.82
- PAG N/A
- EPS
- BMRN 2.71
- PAG 14.19
- Revenue
- BMRN $2,950,227,000.00
- PAG $30,611,900,000.00
- Revenue This Year
- BMRN $12.27
- PAG $3.32
- Revenue Next Year
- BMRN $9.99
- PAG $3.96
- P/E Ratio
- BMRN $21.81
- PAG $12.04
- Revenue Growth
- BMRN 19.36
- PAG 3.29
- 52 Week Low
- BMRN $52.93
- PAG $134.05
- 52 Week High
- BMRN $94.85
- PAG $186.33
- Technical
- Relative Strength Index (RSI)
- BMRN 55.66
- PAG 52.99
- Support Level
- BMRN $56.48
- PAG $169.35
- Resistance Level
- BMRN $60.43
- PAG $174.57
- Average True Range (ATR)
- BMRN 1.52
- PAG 4.12
- MACD
- BMRN 0.23
- PAG -0.98
- Stochastic Oscillator
- BMRN 64.05
- PAG 51.95
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About PAG Penske Automotive Group Inc.
Penske Automotive Group operates in 19 US states and overseas. It has over 150 US and Puerto Rico light-vehicle stores as well as 210 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Germany, Italy, and Japan. The company is the third-largest US publicly traded dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 45 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns 16 used-vehicle stores, mostly in the US and UK under the CarShop (US) and Sytner Select (UK) brands. Penske is based in Bloomfield Hills, Michigan.